Targeting the metabolism of glycosphingolipids as a novel therapeutic strategy for MND (Cure for MND grant administered by the Florey Institute of Neuroscience and Mental Health) (2017–2021)

Grant type:
The Florey Institute of Neuroscience and Mental Health
Researchers:
  • Principal Research Fellow
    Australian Institute for Bioengineering and Nanotechnology
    Principal Research Fellow
    Australian Institute for Bioengineering and Nanotechnology
Funded by:
Florey Institute of Neuroscience and Mental Health, The